Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Neuropharmacology. 2009 Jun 21;58(1):117–125. doi: 10.1016/j.neuropharm.2009.06.009

Figure 4.

Figure 4

The effects of subcutaneous injections of the D2 agonist quinpirole on Fos and aromatase (ARO) colocalization within vasotocin (VT) neurons in the medial bed nucleus of the stria terminalis (BSTm) of male zebra finches. (A) Relative to treatment with 0.9% NaCl vehicle alone, subcutaneous injection of 1 mg/kg of the D2 agonist failed to affect Fos colocalization with VT at the rostral (n=20, p=0.21) or caudal (n=20, p=0.12) BSTm. (B) Treatment with the D2 agonist did increase ARO colocalization with VT in the caudal (n=20, p=0.049), though not rostral (n=20, p=0.74), BSTm. (C) Overall, treatment with the D2 agonist increased Fos+ARO colocalization with VT (triple labeling) in the caudal (n=20, p=0.024), though not rostral (n=20, p=0.16), BSTm. Bars represent means + 1 S.E.M. * indicates treatment groups differing at p<0.05.